Company Profile
Avery Therapeutics, Inc.
Company Overview
Avery Therapeutics, Inc. is a leader in the development of next-generation bioengineered therapeutics for cardiac diseases, such as chronic heart failure. Avery’s dedicated and passionate team has the unique privilege of making significant contributions to groundbreaking therapies that address large unmet medical needs. As a late-stage pre-clinical company, each member is a difference maker and is paving the path for novel and needed treatments.
Company History
Avery started operations in 2016, with the intent to commercialize products based on a tissue engineering technology that was licensed from the University of Arizona. Avery has built upon the technology to create a pipeline of robust therapeutic products. Avery has an enthusiastic, hardworking management team with core values of positivity, self-improvement, and doing good in the world. Avery has expanded its team and continues to seek like-minded individuals that can bring new areas of expertise. Avery anticipates growing to a team of about 10 individuals over the next year. This team will be conducting important foundational activities to move products into clinical trials and build a strong and sustainable business. This is an excellent opportunity to join a new company in an exciting space with high growth potential.